Ddd Partners, LLC Editas Medicine, Inc. Transaction History

Ddd Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$26.55 - $40.57 $6.11 Million - $9.34 Million	-230,221 Closed	0 $0
Q3 2021 Oct 22, 2021	SELL	$39.27 - $72.94 $3.54 Million - $6.58 Million	-90,170 Reduced 28.14%	230,221 $9.46 Million
Q2 2021 Aug 04, 2021	BUY	$31.29 - $56.64 $3.05 Million - $5.52 Million	97,415 Added 43.69%	320,391 $18.1 Million
Q1 2021 May 03, 2021	BUY	$39.71 - $90.58 $5.7 Million - $13 Million	143,449 Added 180.38%	222,976 $9.37 Million
Q4 2020 Feb 09, 2021	BUY	$27.07 - $84.35 $2.15 Million - $6.71 Million	79,527 New	79,527 $5.58 Million

225

54.2M

412K

355K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $132M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Ddd Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ddd Partners, LLC with notifications on news.